Skip to main content

Table 1 Clinicopathologic characteristics of miR-206

From: MicroRNA-206 suppresses gastric cancer cell growth and metastasis

Categories NO. of patients Relative levels of miR-206 (mean ± SEM) P-value
Gender    
Male 21 0.49 ± 0.07 0.32
Female 14 0.40 ± 0.06  
Age (years)    
≥60 19 0.45 ± 0.05 0.93
<60 16 0.46 ± 0.09  
Diameter (cm)    
≥5 13 0.46 ± 0.09 0.90
<5 22 0.45 ± 0.05  
Location    
Middle and proximal third 23 0.47 ± 0.06 0.65
Distal third 12 0.42 ± 0.07  
Degree of differentiation    
well and moderately 12 0.48 ± 0.07 0.70
Poorly 23 0.44 ± 0.07  
Local invasion    
T1 + T2 10 0.65 ± 0.07 0.01
T3 + T4 25 0.37 ± 0.05  
Lymph node metastasis    
NO 14 0.57 ± 0.06 0.04
YES 21 0.38 ± 0.07  
TNM stage    
I + II 12 0.60 ± 0.07 0.02
III + IV 23 0.38 ± 0.06